Edible Garden's Protein Pivot Is Real — Its Balance Sheet Is the Story
Gross margin more than doubled to 23.9% and a private-label RTD award landed, yet the equity is down 88% in 90 days. The operating fix is credible; the funding structure for Prairie Hills is what the tape is voting on.
EDBL · Earnings Call · 2026-11-16
A quarter that worked, against a chart that doesn't
Edible Garden's third quarter was, on the numbers, the best operational quarter the company has produced in years. Revenue rose 14% to $3.2 million, and “Gross profit rose 181.7% to approximately $800,000 and gross margin more than doubled to 23.9% compared with 9.7% a year ago” — James Kras, Chief Executive Officer · 2026-11-16 — in what management correctly calls its seasonally slowest period. Cost of goods sold fell 4% while volume rose, SG&A slipped to $2.7 million from $3.0 million, and the net loss narrowed 37% to $2.5 million. Nine-month operating cash use dropped 57% to $3.9 million. Then there is the tape. The stock peaked at $4.20 on 13 July 2026 and has fallen 87.9% in the ninety trading days since; the full series since its 2022 listing is effectively a total loss. That divergence is the whole dossier: the P&L is inflecting while the equity is being priced for something else entirely — and the something else is the financing of Prairie Hills and a near-empty unrestricted cash balance. Asked directly whether the gross margin is durable, the CEO did not hedge: “Sure. Well, first of all, it's sustainable. We've made quite a bit of improvements in streamlining the operations.” — James Kras, Chief Executive Officer · 2026-11-16 The filed history argues for caution. The last filed gross margin (10-Q filed 14 August, period ended 5 May 2026) sat at zero after a two-year stretch in which the quarterly figure swung from deeply negative to the high-30s. Note the staleness: those fundamentals pre-date the quarter being discussed, so Q3's 23.9% is not yet in the filed series. Treat the improvement as real but unproven across a cycle.What is genuinely new: Kandy Fork and Square Roots
Two themes appear in this quarter's keyword set for the first time in the company's history — and both are operating model changes rather than marketing language. The first is the agreement with Kandy Fork Farms, under which Edible Garden hands selected growing to a partner in Tennessee. Kras sized it precisely: it will account for “conservatively, probably between 30% and 40% over time” — James Kras, Chief Executive Officer · 2026-11-16 of production, with a stated cost reduction north of 12% on the transitioned volume, beginning in Q4 and substantially done in 2027. That is a margin lever that does not require capital. The second is Square Roots, the Kimbal Musk–co-founded agtech partner, now tied to a plant-based product line to be launched at Expo West next March. Combined with nutrition categories and plant based, this is the company's Farm to Formula strategy finally acquiring a second leg beyond milk-protein RTDs. Here is the contrast worth holding onto: these themes are company-unique, not a market wave. The global context shows no protein-beverage or RTD cluster moving across the top keywords or the multi-window price tape. Where the market does have a related cluster — private label offering — the 360-day tape has it as a decliner, with Pool, Coupang and Pilgrim's in the basket. Edible Garden is rowing into a private-label opportunity while the public private-label complex de-rates. That is either early or wrong, and nothing in the global data adjudicates it. What management has quietly stopped talking about is just as telling. Kick Sports Nutrition, Pickle Party and Vitamin Whey — all top-30 company keywords within the last four quarters — are absent from the current set. The keyword momentum on Sport Nutrition collapsed in the prior quarter, alongside Private label and Tetra Pak. The branded CPG portfolio has been written out of the narrative in favour of co-manufactured private label.The plant that was already sold out now needs a co-man
The most revealing shift is Prairie Hills. Two quarters ago it was the company's number-one keyword; this quarter it survives only as Prairie Hills property — a real-estate transaction, not a manufacturing ramp. And the framing has changed. In August the CEO told analysts:Whereas in March he had said the goal “is to sell out the plant in the next 90 days or so.” — James Kras, Chief Executive Officer · 2026-03-31 Today the language is softer — “We have secured a tremendous amount of volume already for our plant” — James Kras, Chief Executive Officer · 2026-11-16 — and the go-to-market sequence has quietly inverted: volume now starts at a co-manufacturer, with the Iowa plant following. That is three consecutive quarters of a 100%-sold-out facility that has not yet produced a bottle. The first bottle off the line is still guided to late 2027. Meanwhile the property itself was bought for $6.3 million after quarter-end, paid in Series B preferred stock and a five-year secured note — equity and debt issued into a microcap already trading below a dollar. The balance sheet leaves little room: “Cash and restricted cash was approximately $5.6 million at September 30, 2026, of which $4.4 million is restricted cash” — Jonathan Gutoski, Chief Financial Officer · 2026-11-16 — roughly $1.2 million of genuinely available liquidity against a $2.5 million quarterly net loss. Effective net cash sits near negative $3 million, well below its 2022 high. Against that, the improvement in burn is the genuine bull case: Free cash flow less stock comp turned modestly positive in the last filed quarter, with operating cash use down more than half year-to-date.We've got presold commitments for 100% of the facility, which is just unheard of, which tells you an idea of what the demand is there.